A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Orticumab in Participants with Prior Myocardial Infarction who have Elevated Coronary Inflammation Based on Fat Attenuation Index (FAI) Score Assessed by Coronary Computed Tomography Angiography (CCTA) (FORTIFY)

Principal Investigator

Prof Charalambos Antoniades

Contact us

Email: cvm_nurses@cardiov.ox.ac.uk

IRAS number

1012157